<DOC>
	<DOC>NCT00744549</DOC>
	<brief_summary>The purpose of this study is to determine whether antioxidants (vitamin E, selenium and lycopene)can change(reduce)prostate tumor size or blood flow to the prostate as determined by MRI imaging among men on Active Surveillance.</brief_summary>
	<brief_title>Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<criteria>MRI detectable prostate cancer PSA less than 15 ng/ml Gleason score &lt;= 7 Prostate cancer staging T1c or T2a Concurrent use of highdose vitamins which include selenium, lycopene, vitamin D or vitamin E Other malignancies diagnosed or requiring treatment within the past 5 years (except superficial bladder cancer or basal cell carcinoma) Current use of Proscar or Avodart</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Male Urogenital Diseases</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>Vitamin E</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Lycopene</keyword>
	<keyword>Selenium</keyword>
</DOC>